Whoop, a prominent player in the wearable technology sector, has successfully concluded its Series G funding round, raising an impressive $575 million. This capital injection has propelled the company's valuation to a remarkable $10.1 billion, signifying strong investor confidence in its future trajectory. With a focus on human performance and health, Whoop distinguishes itself with advanced fitness trackers that offer comprehensive insights into users' physiological data, including recovery, sleep patterns, and physical strain. The firm recently achieved a significant milestone by securing FDA clearance for medical-grade ECG and blood pressure monitoring in its new Whoop MG model, marking a strategic pivot towards clinical health integration. Bolstered by celebrity investors such as Cristiano Ronaldo and LeBron James, Whoop is poised for continued expansion and innovation in the competitive wearable market.
Whoop Raises $575 Million in Series G Funding, Valued at $10.1 Billion
In a significant development for the wearable technology industry, Whoop, a company specializing in human performance and health monitoring, announced on Tuesday, March 31, 2026, the successful completion of its Series G funding round, amassing $575 million. This substantial investment elevates Whoop's valuation to an impressive $10.1 billion, positioning it as a formidable competitor in the market, notably surpassing the $1.6 billion valuation of rival Oura Health's recent Series G round. The latest funding initiative was spearheaded by Collaborative Fund, with notable contributions from a diverse group of investors including 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital, Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, and Bullhound Capital. Furthermore, the round attracted investments from high-profile athletes and public figures such as Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, Niall Horan, Karen Wazen, Virgil van Dijk, and Shane Lowry, underscoring the brand's appeal and credibility within the athletic community. This new capital infusion places Whoop among the most valuable private companies globally, according to financial data, closely trailing Shield AI and Kraken in terms of valuation. The company reported a robust 2.5 million members and a remarkable 103% year-over-year growth in bookings, concluding 2025 with an estimated $1.1 billion bookings run rate and positive operating cash flow. Whoop's innovative subscription-based model provides users with a screenless wearable device designed for 24/7 physiological data collection, offering distinct advantages over traditional smartwatches like the Apple Watch by prioritizing deep health insights over notifications. The introduction of Whoop 5.0 and the FDA-cleared Whoop MG, featuring medical-grade ECG and blood pressure monitoring, signifies the company's deepening commitment to integrating clinical health functionalities. Moreover, the platform leverages its advanced "Whoop Coach" AI to deliver personalized training and wellness recommendations, continually enhancing the user experience. The annual membership for Whoop is priced at $239 as of early 2026, with the device included at no upfront cost.
This remarkable funding achievement for Whoop not only highlights the booming potential of health and fitness wearable technology but also signals a broader trend towards integrating advanced data analytics and medical-grade functionalities into consumer devices. The involvement of such diverse and high-profile investors, from major investment firms to global sports icons, suggests a strong belief in Whoop's vision of empowering individuals to optimize their health and performance. As Whoop continues to innovate with features like FDA-cleared monitoring and AI-powered coaching, it is setting new benchmarks for the industry, promising a future where personalized health management is more accessible and precise than ever before. This development reinforces the idea that wearable technology is evolving beyond simple activity tracking to become an essential tool for comprehensive health and wellness, offering invaluable insights for both everyday users and elite athletes.